James E. Levine, Chief Financial Officer at Cardiff Oncology, Inc. (CRDF), bought 30,000 shares at $1.56 ($47K) on 2022-09-16, disclosed to the SEC on 2022-09-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CDTX | BUY | 2020-11-12 | $201K | — | Filing → |
| CDTX | BUY | 2020-03-23 | $57K | — | Filing → |
| VRNM | BUY | 2012-05-16 | $18K | — | Filing → |